Psoriatic Arthritis

Latest News

Increased HLA-B27 Associated With More Severe Sonographic Enthesitis in PsA

Increased HLA-B27 Associated With More Severe Sonographic Enthesitis in PsA

In patients with psoriatic arthritis, increasing levels of HLA-B27 are associated with more severe sonographic enthesitis.

Spondyloarthritis Increases Risk for Dysrhythmias and Aortic Regurgitation

Spondyloarthritis Increases Risk for Dysrhythmias and Aortic Regurgitation

The risk for aortic regurgitation and cardiac rhythm abnormalities was evaluated in a nationwide cohort of patients with spondyloarthritis.

Efficacy and Safety of Ixekizumab Evaluated in Active Psoriatic Arthritis

Efficacy and Safety of Ixekizumab Evaluated in Active Psoriatic Arthritis

Results from the phase 3 SPIRIT-P1 study show that treatment with ixekizumab every 2 or 4 weeks in patients with active psoriatic arthritis demonstrated sustained efficacy and a favorable safety profile.

Efficacy of Apremilast Monotherapy Assessed in Biologic-Naive Psoriatic Arthritis

Efficacy of Apremilast Monotherapy Assessed in Biologic-Naive Psoriatic Arthritis

Patients with psoriatic arthritis who are taking apremilast experienced early symptom relief and sustained clinical improvement through 1 year of treatment.

Hyperuricemia in Psoriatic Arthritis: Identifying Features to Improve Outcomes

Hyperuricemia in Psoriatic Arthritis: Identifying Features to Improve Outcomes

A cohort study was conducted to determine the long-term outcomes especially of cardiovascular and kidney diseases in patients with psoriatic arthritis with comorbid hyperuricemia.

Risk of Liver Disease Increased With Psoriatic Arthritis

Risk of Liver Disease Increased With Psoriatic Arthritis

There is a higher risk for liver disease in patients with inflammatory disorders.

JAK Inhibitors Now Approved For Treatment of Active Psoriatic Arthritis

JAK Inhibitors Now Approved For Treatment of Active Psoriatic Arthritis

The FDA has approved tofacitinib and tofacitinib extended release to treat active psoriatic arthritis.

Overlap Between Remission and Low Disease Activity Targets in Psoriatic Arthritis

Overlap Between Remission and Low Disease Activity Targets in Psoriatic Arthritis

Investigators compared composite scores defining low disease activity state or remission in an existing real-life data set of patients with PsA.

Examining the Implications of Accelerated Coronary Plaque Formation in Psoriatic Arthritis

Examining the Implications of Accelerated Coronary Plaque Formation in Psoriatic Arthritis

Disease severity and activity in psoriatic arthritis may predict coronary plaque burden better than traditional risk factors.

Characterization of Rheumatic Disorders Associated With Immune Checkpoint Inhibitor Use

Characterization of Rheumatic Disorders Associated With Immune Checkpoint Inhibitor Use

A prospective, observational study sought to evaluate and characterize the nature of rheumatic disorders associated with immune checkpoint inhibitors.

Sign Up for Free e-newsletters